Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

The European Pediatric Pharmaceutical Legislation wants children to benefit more from pharmaceutical progress. In rare diseases, concerns have been raised that this legislation might damage research and stymie drug development. We discuss the role of the European Medicines Agency (EMA) and its Pedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Klaus, Spigarelli, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928746/
https://www.ncbi.nlm.nih.gov/pubmed/27417354
http://dx.doi.org/10.3390/children2010108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928746/
https://www.ncbi.nlm.nih.gov/pubmed/27417354
http://dx.doi.org/10.3390/children2010108

Ejemplares similares